Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
This report contains market size and forecasts of Rasagiline Tablet in global, including the following market information:
Global Rasagiline Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rasagiline Tablet Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Rasagiline Tablet companies in 2021 (%)
The global Rasagiline Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.5 mg/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rasagiline Tablet include Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz and Intas Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rasagiline Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rasagiline Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Rasagiline Tablet Market Segment Percentages, by Type, 2021 (%)
0.5 mg/Pcs
1 mg/Pcs
Global Rasagiline Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Rasagiline Tablet Market Segment Percentages, by Application, 2021 (%)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Global Rasagiline Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Rasagiline Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rasagiline Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rasagiline Tablet revenues share in global market, 2021 (%)
Key companies Rasagiline Tablet sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Rasagiline Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Lundbeck
Sun Pharmaceutical
Apotex
Taj Pharma
Mylan
Takeda Pharmaceutical
Sandoz
Intas Pharmaceuticals
Natco Pharma
Ajanta Pharma
Orchid Pharma
Alkem Laboratories